FDA OKs New-Generation Heart Defibrillators

Wednesday, 16 Apr 2014 12:02 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
 
U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

The Food and Drug Administration approved for sale the Dynagen Mini and Inogen Mini ICDs and the Dynagen X4 and Inogen X4 CRT-Ds, Boston Scientific said.

The Mini ICDs are up to 20 percent smaller by volume and up to 24 percent thinner than rival devices from other companies, Boston Scientific said. Implantable cardioverter defibrillators treat arrhythmias by shocking a dangerously racing heartbeat back into normal rhythms.

Special: The Two Signs Your Heart Is In Trouble

"The tiny size of the Mini ICD provides a real benefit to some patients, in particular those with a smaller frame," Dr. Hans-Joachim Trappe from University Marien Hospital Herne, Hospital of Ruhr-University, Bochum, Germany, said in a statement.

The CRT-Ds, or cardiac resynchronization therapy defibrillators, are also used to protect against sudden cardiac death due to abnormal heart rhythms in patients suffering from heart failure, in which the heart is unable to pump blood sufficiently.

Boston Scientific shares rose to $13.45 in extended trading on Tuesday from a New York Stock Exchange close of $13.35.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Why 7 Hours of Sleep Might Be Better Than 8

Tuesday, 22 Jul 2014 09:11 AM

We've all probably heard the advice from sleep scientists that seven to nine hours a night of shut-eye is optimum for he . . .

Old Cancer Drug Rouses Hidden HIV for Treatment

Tuesday, 22 Jul 2014 08:30 AM

AIDS researchers seeking to cure HIV with a one-two punch got an early hint the approach may work by successfully using  . . .

Asthma Drug Treats Chronic Hives

Tuesday, 22 Jul 2014 08:18 AM

A drug already used to treat moderate-to-severe allergic asthma appears to offer relief to people with chronic hives who . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved